| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |